Abstract: A composite material for purifying air includes a porous foam material which is an open-cell polyurethane foam net; and a mixture sprayed on the interior and/or the surface of the porous foam material, the mixture including an absorbent material, a treating agent and an adhesive; wherein the adsorptive material is diatomite, and the treating agent is alkali solution.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: A direct current electrical power system having AC grid power attached to the bus through AC/DC converter, PV panel attached to the bus through DC/DC pre-conditioner, a first direct current load attached directly to the bus, and a second direct current load attached to the bus through a DC/DC converter. The function of the AC grid and AC/DC converter is to create and regulate the DC bus voltage. The function of the PV power is to provide as much power as required to the DC loads. Since the conversion efficiency of the DC/DC pre-conditioner is much higher than that of the AC/DC converter, the conversion loss is greatly reduced if the load is mainly powered from PV instead of AC grid. In addition, a battery can be attached to the bus through a battery charger/controller, which is a bi-directional DC/DC converter.

Abstract: A case (330) for a vibrating meter (300) is provided. The case (330) includes a first panel (331a) defined by at least a first edge (333) and a second edge (334). The case (330) also includes one or more indentations (332) formed in the first panel (331a). The one or more indentations (332) include at least a portion extending from the first edge (333) to the second edge (334). The resonant frequencies of the case can be increased and separated from the intended drive frequencies of the fluid conduits (306A, 306B).

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: Disclosed is the use of an inverse agonist for alpha-subunit-containing gamma-aminobutyric acid A receptor in the preparation of a medicine for the prevention, alleviation, or treatment of pain.

Abstract: Methods, systems, and computer-readable media for evaluating the quality of text within online advertisements using output from a language model are provided. The output from the language model may be used by a machine-learning algorithm to generate a quality score for an individual advertisement. The quality score may be used to filter out advertisements with poor text quality or to tax or penalize an advertisement within an online auction. The ad quality scores may also be used to rank or score advertisers that submit the ads. In one embodiment, the advertiser's quality score is combined with an individual ad's quality score to create a final score, which is used to evaluate the advertisement. The advertiser rank/score and ad quality score may be communicated to an advertiser as advertiser feedback.

Abstract: A case (330) for a vibrating meter (300) is provided. The case (330) includes a first panel (331a) defined by at least a first edge (333) and a second edge (334). The case (330) also includes one or more indentations (332) formed in the first panel (331a). The one or more indentations (332) include at least a portion extending from the first edge (333) to the second edge (334). The resonant frequencies of the case can be increased and separated from the intended drive frequencies of the fluid conduits (306A, 306B).

Abstract: Novel compounds of structure Formula I: or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, wherein A, D, Di, E, J, L, n, Q, R2 and R4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Abstract: Novel compounds of structure Formula I: or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, wherein A, L, m, n, o, p, R2, R3, R3, R4 and R5 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Abstract: The present invention disclosed a medical use of cucurbitane triterpenoids represented by the following formula and isolated from Momordica charantia L. of Cucurbitaceae family in the preparation of medications for prevention and treatment of diabetes and obesity. The above cucurbitane triterpenoids may be acted as a glucose uptake stimulator, an agonist for the translocation of glucose transporter 4 (GLUT4) to the cell membrane, and an activator of adenosine monophosphate-activated protein kinase (AMPK). They may have potential for the prevention and treatment of diabetes and obesity.

Abstract: Novel compounds of structure Formula I: or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, where-in A, L, m, n, o, p, R2, R3, R3, R4 and R5 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Abstract: Novel compounds of structure Formula I: or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, wherein A, D, Di, E, J, L, n, Q, R2 and R4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Abstract: According to the features discussed herein, through a single generalized arc-fault detection algorithm, various types of series and/or parallel arc faults can be detected without any nuisance trip for either AC or DC Electric Power Systems. Running Discrete Fourier Series (RDFS) formulation for nuisance-free operation and cost-effective implementation is developed. Unlike other methods which require numerous source and load-side current and voltage measurements, only source side current is required. An arc detector may include a first detector to monitor variations of a magnitude of a fundamental component of a current, and a second detector to monitor an overload condition based in an i2t calculation.

Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.

Abstract: Techniques for providing mining life pattern are described. This disclosure describes mining a life pattern of an individual, for example, by identifying places visited during the individual's daily activities. Mining the individual life pattern includes collecting location data for the individual and predicting behaviors and preferences of the individual based at least in part on a location history. The location history of the individual is represented with a sequence of geographical regions that have been visited by the individual with corresponding arrival and departure times for each region. Once the life pattern is predicted from the location history, information is recommended to the individual based at least in part on the life pattern.